tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Edesa Biotech’s ARDS Study: A Breath of Fresh Air for Investors?
PremiumCompany AnnouncementsEdesa Biotech’s ARDS Study: A Breath of Fresh Air for Investors?
3M ago
Edesa Biotech Advances ARDS Treatment with JUST BREATHE Study
Premium
Company Announcements
Edesa Biotech Advances ARDS Treatment with JUST BREATHE Study
3M ago
Edesa Biotech’s ARDS Trial: A Breath of Fresh Air for Innovative Therapies
Premium
Company Announcements
Edesa Biotech’s ARDS Trial: A Breath of Fresh Air for Innovative Therapies
3M ago
Edesa Biotech initiated with a Buy at Lucid Capital
PremiumThe FlyEdesa Biotech initiated with a Buy at Lucid Capital
4M ago
Edesa Biotech Shifts Focus to Vitiligo Treatment in Q2 2025
Premium
Company Announcements
Edesa Biotech Shifts Focus to Vitiligo Treatment in Q2 2025
5M ago
Is EDSA a Buy, Before Earnings?
Premium
Pre-Earnings
Is EDSA a Buy, Before Earnings?
5M ago
Edesa Biotech Advances Vitiligo Treatment Amidst Solid Financial Backing
PremiumCompany AnnouncementsEdesa Biotech Advances Vitiligo Treatment Amidst Solid Financial Backing
8M ago
Edesa Biotech announces $15M private placement priced at-the-market
Premium
The Fly
Edesa Biotech announces $15M private placement priced at-the-market
8M ago
Edesa Biotech Secures $15 Million in Private Placement to Advance Clinical Programs
Premium
Company Announcements
Edesa Biotech Secures $15 Million in Private Placement to Advance Clinical Programs
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100